Renalis is creating a suite of prescribed digital therapeutics (PDT) designed for patients with pelvic health disorders such as overactive bladder (OAB), fecal incontinence, fibroids, endometriosis or chronic pelvic pain. The company's first go-to-market platform for fibroids/endo will be available 3Q20, followed by another for OAB, for which the company anticipates seeking FDA approval in 2021 following clinical trials. Renalis is based in Chicago at MATTER, but serves a global market.
Renalis Address
11459 Mayfield Rd Chicago, IL United States
Renalis Email
Past Companies
RenalisLead Product Designer
FreelanceUser Experience Design, Strategy, and User Research
University of Advancing TechnologyHuman Computer Interaction Adjunct Faculty